Patent ID: 11857555
Assignee: ANTARES PHARMA, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A | IPC A

Claim 3:
4. The aqueous pharmaceutical formulation of claim 1, comprising 130 mg/mL hydrocortisone sodium phosphate, 131 mg/mL hydrocortisone sodium phosphate, 132 mg/mL hydrocortisone sodium phosphate, 133 mg/mL hydrocortisone sodium phosphate, 134 mg/mL hydrocortisone sodium phosphate, about 135 mg/mL hydrocortisone sodium phosphate, 136 mg/mL hydrocortisone sodium phosphate, 137 mg/mL hydrocortisone sodium phosphate, 138 mg/mL hydrocortisone sodium phosphate, 139 mg/mL hydrocortisone sodium phosphate, or 140 mg/mL hydrocortisone sodium phosphate.